Primary small cell carcinoma of the vagina

Joseph M. Kaminski, Penny R. Anderson, Aaron C. Han, Raj K. Mitra, Norman G. Rosenblum, Mitchell I. Edelson

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background. Primary vaginal small cell carcinoma is extremely rare, with a total number reported in English-language journals to date of 23. Most patients die of the disease within 2 years of diagnosis from metastatic disease. Case. A 69-year-old woman presented with vaginal spotting while on Premarin. She was subsequently diagnosed with Stage I (T1N0M0) small cell carcinoma of the vagina. She underwent concurrent chemoradiation and then brachytherapy for persistent disease. Due to residual disease after the brachytherapy, surgical resection was planned but aborted because of metastatic disease. Conclusion. Of the three reported cases treated with concurrent chemoradiation, ours is the first case reported with persistent local disease after therapy. Extrapolating from the available clinical trials from lung carcinoma, concurrent chemoradiation as a primary treatment approach should still be considered.

Original languageEnglish (US)
Pages (from-to)451-455
Number of pages5
JournalGynecologic Oncology
Volume88
Issue number3
DOIs
StatePublished - Mar 1 2003

Fingerprint

Small Cell Carcinoma
Vagina
Brachytherapy
Conjugated (USP) Estrogens
Metrorrhagia
Language
Clinical Trials
Carcinoma
Lung
Therapeutics

Keywords

  • Chemotherapy
  • Radiation
  • Small cell carcinoma
  • Vagina

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Kaminski, J. M., Anderson, P. R., Han, A. C., Mitra, R. K., Rosenblum, N. G., & Edelson, M. I. (2003). Primary small cell carcinoma of the vagina. Gynecologic Oncology, 88(3), 451-455. https://doi.org/10.1016/S0090-8258(02)00153-1

Primary small cell carcinoma of the vagina. / Kaminski, Joseph M.; Anderson, Penny R.; Han, Aaron C.; Mitra, Raj K.; Rosenblum, Norman G.; Edelson, Mitchell I.

In: Gynecologic Oncology, Vol. 88, No. 3, 01.03.2003, p. 451-455.

Research output: Contribution to journalArticle

Kaminski, JM, Anderson, PR, Han, AC, Mitra, RK, Rosenblum, NG & Edelson, MI 2003, 'Primary small cell carcinoma of the vagina', Gynecologic Oncology, vol. 88, no. 3, pp. 451-455. https://doi.org/10.1016/S0090-8258(02)00153-1
Kaminski JM, Anderson PR, Han AC, Mitra RK, Rosenblum NG, Edelson MI. Primary small cell carcinoma of the vagina. Gynecologic Oncology. 2003 Mar 1;88(3):451-455. https://doi.org/10.1016/S0090-8258(02)00153-1
Kaminski, Joseph M. ; Anderson, Penny R. ; Han, Aaron C. ; Mitra, Raj K. ; Rosenblum, Norman G. ; Edelson, Mitchell I. / Primary small cell carcinoma of the vagina. In: Gynecologic Oncology. 2003 ; Vol. 88, No. 3. pp. 451-455.
@article{2ab94a416a6c412d8dafd60d2428bc3c,
title = "Primary small cell carcinoma of the vagina",
abstract = "Background. Primary vaginal small cell carcinoma is extremely rare, with a total number reported in English-language journals to date of 23. Most patients die of the disease within 2 years of diagnosis from metastatic disease. Case. A 69-year-old woman presented with vaginal spotting while on Premarin. She was subsequently diagnosed with Stage I (T1N0M0) small cell carcinoma of the vagina. She underwent concurrent chemoradiation and then brachytherapy for persistent disease. Due to residual disease after the brachytherapy, surgical resection was planned but aborted because of metastatic disease. Conclusion. Of the three reported cases treated with concurrent chemoradiation, ours is the first case reported with persistent local disease after therapy. Extrapolating from the available clinical trials from lung carcinoma, concurrent chemoradiation as a primary treatment approach should still be considered.",
keywords = "Chemotherapy, Radiation, Small cell carcinoma, Vagina",
author = "Kaminski, {Joseph M.} and Anderson, {Penny R.} and Han, {Aaron C.} and Mitra, {Raj K.} and Rosenblum, {Norman G.} and Edelson, {Mitchell I.}",
year = "2003",
month = "3",
day = "1",
doi = "10.1016/S0090-8258(02)00153-1",
language = "English (US)",
volume = "88",
pages = "451--455",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Primary small cell carcinoma of the vagina

AU - Kaminski, Joseph M.

AU - Anderson, Penny R.

AU - Han, Aaron C.

AU - Mitra, Raj K.

AU - Rosenblum, Norman G.

AU - Edelson, Mitchell I.

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Background. Primary vaginal small cell carcinoma is extremely rare, with a total number reported in English-language journals to date of 23. Most patients die of the disease within 2 years of diagnosis from metastatic disease. Case. A 69-year-old woman presented with vaginal spotting while on Premarin. She was subsequently diagnosed with Stage I (T1N0M0) small cell carcinoma of the vagina. She underwent concurrent chemoradiation and then brachytherapy for persistent disease. Due to residual disease after the brachytherapy, surgical resection was planned but aborted because of metastatic disease. Conclusion. Of the three reported cases treated with concurrent chemoradiation, ours is the first case reported with persistent local disease after therapy. Extrapolating from the available clinical trials from lung carcinoma, concurrent chemoradiation as a primary treatment approach should still be considered.

AB - Background. Primary vaginal small cell carcinoma is extremely rare, with a total number reported in English-language journals to date of 23. Most patients die of the disease within 2 years of diagnosis from metastatic disease. Case. A 69-year-old woman presented with vaginal spotting while on Premarin. She was subsequently diagnosed with Stage I (T1N0M0) small cell carcinoma of the vagina. She underwent concurrent chemoradiation and then brachytherapy for persistent disease. Due to residual disease after the brachytherapy, surgical resection was planned but aborted because of metastatic disease. Conclusion. Of the three reported cases treated with concurrent chemoradiation, ours is the first case reported with persistent local disease after therapy. Extrapolating from the available clinical trials from lung carcinoma, concurrent chemoradiation as a primary treatment approach should still be considered.

KW - Chemotherapy

KW - Radiation

KW - Small cell carcinoma

KW - Vagina

UR - http://www.scopus.com/inward/record.url?scp=0037340755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037340755&partnerID=8YFLogxK

U2 - 10.1016/S0090-8258(02)00153-1

DO - 10.1016/S0090-8258(02)00153-1

M3 - Article

VL - 88

SP - 451

EP - 455

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -